News Alembic Limited NSE India S.E.

Equities

ALEMBICLTD

INE426A01027

Market Closed - NSE India S.E. Other stock markets 07:43:46 2024-04-26 am EDT			5-day change	1st Jan Change
94.35 ^INR	-0.42%		+1.78%	+4.25%

Apr. 02	Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	MT
Apr. 01	Alembic Limited Announces Cessation of C. P. Buch as an Independent Director	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3%	Apr. 18	MT
Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	Apr. 02	MT
Alembic Limited Announces Cessation of C. P. Buch as an Independent Director	Apr. 01	CI
Alembic Pharmaceuticals' Oncology Plant in Gujarat, India Gets One Observation from US FDA	Mar. 11	MT
Crisil Keeps AA+ Rating on Alembic Pharmaceuticals' Bank Loans with Stable Outlook	Mar. 08	MT
ICRA Affirms AA- Rating on Alembic's Bank Financing; Outlook Stable	Feb. 29	MT
Indian shares seen muted tracking broader Asian equities	Feb. 25	RE
Alembic Pharmaceuticals Fully Resumes Operations at Manufacturing Unit in South Sikkim, India	Feb. 23	MT
Alembic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates	Feb. 06	MT
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates	Feb. 06	MT
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales	Feb. 05	RE
North American Morning Briefing : Jobs Report Tops -2-	Feb. 02	DJ
North American Morning Briefing : Microsoft Kicks -2-	Jan. 30	DJ
North American Morning Briefing : Stock Futures -2-	Jan. 23	DJ
Alembic Pharmaceuticals Expects Operations at Sikkim, India Units to Be Restores in Two Months	Jan. 05	MT
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit	Jan. 02	MT
North American Morning Briefing : Stock Futures -2-	Nov. 16	DJ
Alembic Pharmaceuticals Logs Slightly Higher Consolidated Profit in Fiscal Q2; EPS Misses Estimates	Nov. 08	MT
India's Alembic Pharma Q2 profit roughly in-line with estimates	Nov. 07	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Alembic Limited NSE India S.E.

Equities

ALEMBICLTD

INE426A01027

Summary

Filters